Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2025-01-03T15:50:00.076Z Has data issue: false hasContentIssue false
  • English
  • Français

A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity

Published online by Cambridge University Press:  09 July 2009

Thomas P. Hogan ,
A. G. Awad  and
Robin Eastwood
Thomas P. Hogan*
Affiliation:
Queen Street Mental Health CentreClarke Institute of Psychiatry, Toronto, Canada
A. G. Awad
Affiliation:
Queen Street Mental Health CentreClarke Institute of Psychiatry, Toronto, Canada
Robin Eastwood
Affiliation:
Queen Street Mental Health CentreClarke Institute of Psychiatry, Toronto, Canada
*
1Address for correspondence: Mr T. P. Hogan, Department of Psychology, Queen Street Mental Health Centre, 1001 Queen Street west. Toronto, Canada, M6J 1H4.
Get access Rights & Permissions [Opens in a new window]

Synopsis

Schizophrenic patients' self-reports of their experience of neuroleptic treatment were used as the basis for the construction of a scale predictive of drug compliance. Reliability analysis of the responses of 150 patients indicated high internal consistency in the 30-item scale, and preliminary validation in the form of discriminant classification accurately assigned 89% of the sample to compliant and non-compliant groupings. Both discriminant and factor analyses suggest that maximum variability in responding is accounted for by items reflecting how the patient feels on medication, rather than what he knows or believes about medication.

Type
Research Article
Information
Psychological Medicine , Volume 13 , Issue 1 , February 1983 , pp. 177 - 183
Copyright
Copyright © Cambridge University Press 1983

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bakker, C. B. & Dightman, C. R. (1964). Psychological factors in fertility control. Fertility and Sterility 15, 559–567.CrossRefGoogle ScholarPubMed
Barofsky, I. (1976). Behavioral therapeutics and the management of therapeutic regimens. In Compliance with Therapeutic Regimens (ed. Sackett, D. L. and Haynes, R. B.), pp. 100–109. Johns Hopkins University Press: Baltimore.Google Scholar
Blackwell, B. (1976). Treatment adherence. British Journal of Psychiatry 129, 513–531.CrossRefGoogle ScholarPubMed
Bock, R. D. (1975). Multivariate Statistical Methods in Behavioral Research. McGraw-Hill: New York.Google Scholar
Cialdini, R. B., Petty, R. E. & Cacioppo, J. T. (1981). Attitude and attitude change. Annual Review of Psychology 32, 357–404.CrossRefGoogle Scholar
Comrey, A. L. (1978). Common methodological problems in factor analytic studies. Journal of Consulting and Clinical Psychology 46, 648–659.CrossRefGoogle Scholar
Davis, M. S. (1967). Predicting noncompliant behaviour. Journal of Health and Social Behavior 8, 265–271.CrossRefGoogle Scholar
DiMascio, A. (1970). Behavioral toxicity. In Clinical Handbook of Psychopharmacology (ed. DiMascio, A. and Shader, R. I.), pp. 185–193. Science House: New York.Google Scholar
Falloon, I., Watt, D. C. & Shepherd, M. (1978). A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia. Psychological Medicine 8, 59–70.CrossRefGoogle ScholarPubMed
Harris, C. W. (1967). On factors and factor structure. Psychometrika 4, 363–369.CrossRefGoogle Scholar
Hogarty, G. C., Schooler, N. R., Ulrich, R., Mussare, F., Peregrino, F. & Herron, E. (1979). Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride. Archives of General Psychiatry 36, 1283–1294.CrossRefGoogle ScholarPubMed
Irwin, D. S., Weitzel, W. D. & Morgan, D. W. (1971). Phenothiazine intake and staff attitudes. American Journal of Psychiatry 127, 1631–1635.CrossRefGoogle ScholarPubMed
Kaiser, H. F. & Caffrey, J. (1965). Alpha factor analysis. Psychometrika 30, 1–14.CrossRefGoogle ScholarPubMed
Lipowski, Z. J. (1977). The importance of body experience for psychiatry. Comprehensive Psychiatry 18, 473–479.CrossRefGoogle ScholarPubMed
Michaux, W. W. (1961). Side effects, resistance and dosage deviation in psychiatric outpatients treated with tranquilizers. Journal of Nervous and Mental Disease 133, 203–212.CrossRefGoogle ScholarPubMed
Nevins, D. B. (1977). Adverse response to neuroleptics in schizophrenia. International Journal of Psychoanalytic Psychotherapy 6, 227–241.Google ScholarPubMed
Nunnally, J. C. (1967). Psychometric Theory. McGraw-Hill: New York.Google Scholar
Parkes, C. M., Brown, G. W. & Monck, S. M. (1962). The general practitioner and the schizophrenic patient. British Medical Journal ii, 972–976.CrossRefGoogle Scholar
Raskin, A. A. (1961). A comparison of acceptors and resistors of drug treatment as an adjunct to psychotherapy. Journal of Clinical and Consulting Psychology 25, 366.CrossRefGoogle ScholarPubMed
Reilly, E. L., Wilson, W. P. & McClinton, H. K. (1967). Clinical characteristics and medication history of schizophrenics readmitted to the hospital. International Journal of Neuropsychiatry 3, 85–90.Google Scholar
Renton, C. A., Affleck, J. W., Carstairs, G. M. & Forrest, A. D. (1963). A follow-up of schizophrenic patients in Edinburgh. Acta Psychiatrica Scandinavica 39, 548–600.CrossRefGoogle ScholarPubMed
Richards, A. D. (1964). Attitude and drug acceptance. British Journal of Psychiatry 110, 46–52.CrossRefGoogle ScholarPubMed
Rifkin, A., Quitkin, F. & Klein, D. F. (1975). Akinesia. Archives of General Psychiatry 32, 672–674.CrossRefGoogle Scholar
Rifkin, A., Quitkin, F., Rabiner, C. J. & Klein, D. F. (1977). Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics: I. Relapse rates after one year. Archives of General Psychiatry 34, 43–47.CrossRefGoogle ScholarPubMed
Sackett, D. L. & Haynes, R. B. (eds.) (1976). Compliance with Therapeutic Regimens. John Hopkins University Press: Baltimore.Google Scholar
Scheier, M. F., Carver, C. S. & Gibbons, F. X. (1979). Self-directed attention, awareness of bodily states, and suggestibility. Journal of Personality and Social Psychology 37, 1576–1588.CrossRefGoogle ScholarPubMed
Singh, M. M. (1976). Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance. Diseases of the Nervous System 37, 191–196.Google ScholarPubMed
Soskis, D. A. (1978). Schizophrenic and medical inpatients as informed drug consumers. Archives of General Psychiatry 35, 645–649.CrossRefGoogle ScholarPubMed
Swain, M. A. & Sackett, D. L. (1978). Experimental interventions to predict and improve adherence.Paper presented at the annual meeting of the American Psychological Association,Toronto.Google Scholar
Van Putten, T. (1974). Why do schizophrenic patients refuse to take their drugs? Archives of General Psychiatry 31, 67–72.CrossRefGoogle ScholarPubMed
Van Putten, T. & May, P. R. A. (1978 a). Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point. Archives of General Psychiatry 35, 477–480.CrossRefGoogle ScholarPubMed
Van Putten, T. & May, P. R. A. (1978 b). ‘Akinetic depression’ in schizophrenia. Archives of General Psychiatry 35, 1101–1107.CrossRefGoogle ScholarPubMed
Van Putten, T., May, P. R. A., Marder, S. R. & Wittman, L. A. (1981). Subjective response to antipsychotic drugs. Archives of General Psychiatry 38, 187–190.CrossRefGoogle ScholarPubMed